{"count": 3, "results": [{"_id": "37071471", "pmid": 37071471, "pmcid": "PMC10231999", "title": "Obesity-induced inflammation exacerbates clonal hematopoiesis", "journal": "J Clin Invest", "authors": ["Pasupuleti SK", "Ramdas B", "Burns SS", "Palam LR", "Kanumuri R", "Kumar R", "Pandhiri TR", "Dave UP", "Yellapu NK", "Zhou X", "Zhang C", "Sandusky GE", "Yu Z", "Honigberg MC", "Bick AG", "Griffin GK", "Niroula A", "Ebert BL", "Paczesny S", "Natarajan P", "Kapur R"], "date": "2023-06-01T00:00:00Z", "doi": "10.1172/JCI163968", "meta_date_publication": "2023 Jun 1", "meta_volume": "133", "meta_issue": "11", "meta_pages": "", "score": 50249.12, "text_hl": "@CHEMICAL_Nifedipine @CHEMICAL_MESH:D009543 @@@Nifedipine@@@ inhibits exacerbation of @<m>DISEASE_Cyclic_neutropenia</m> @DISEASE_MESH:C536227 @@@CH@@@ in combination with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_N_(1_2_3_5_6_7_hexahydro_S_indacen_4_ylcarbamoyl)_4_(2_hydroxy_2_propanyl)_2_furansulfonamide @CHEMICAL_MESH:C000597426 @@@MCC950@@@, and anakinra.", "citations": {"NLM": "Pasupuleti SK, Ramdas B, Burns SS, Palam LR, Kanumuri R, Kumar R, Pandhiri TR, Dave UP, Yellapu NK, Zhou X, Zhang C, Sandusky GE, Yu Z, Honigberg MC, Bick AG, Griffin GK, Niroula A, Ebert BL, Paczesny S, Natarajan P, Kapur R. Obesity-induced inflammation exacerbates clonal hematopoiesis J Clin Invest. 2023 Jun 1;133(11):. PMID: 37071471", "BibTeX": "@article{37071471, title={Obesity-induced inflammation exacerbates clonal hematopoiesis}, author={Pasupuleti SK and Ramdas B and Burns SS and Palam LR and Kanumuri R and Kumar R and Pandhiri TR and Dave UP and Yellapu NK and Zhou X and Zhang C and Sandusky GE and Yu Z and Honigberg MC and Bick AG and Griffin GK and Niroula A and Ebert BL and Paczesny S and Natarajan P and Kapur R}, journal={J Clin Invest}, volume={133}, number={11}}"}}, {"_id": "32146550", "pmid": 32146550, "pmcid": "PMC7497683", "title": "Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer", "journal": "Invest New Drugs", "authors": ["Broekman KE", "Hof MAJ", "Touw DJ", "Gietema JA", "Nijman HW", "Lefrandt JD", "Reyners AKL", "Jalving M"], "date": "2020-10-01T00:00:00Z", "doi": "10.1007/s10637-020-00920-7", "meta_date_publication": "2020 Oct", "meta_volume": "38", "meta_issue": "5", "meta_pages": "1454-1462", "score": 50243.547, "text_hl": "No DLTs were observed for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Six @SPECIES_9606 @@@patients@@@ were treated at the 1000 mg tds @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose level. ", "citations": {"NLM": "Broekman KE, Hof MAJ, Touw DJ, Gietema JA, Nijman HW, Lefrandt JD, Reyners AKL, Jalving M. Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer Invest New Drugs. 2020 Oct;38(5):1454-1462. PMID: 32146550", "BibTeX": "@article{32146550, title={Phase I study of metformin in combination with carboplatin/paclitaxel chemotherapy in patients with advanced epithelial ovarian cancer}, author={Broekman KE and Hof MAJ and Touw DJ and Gietema JA and Nijman HW and Lefrandt JD and Reyners AKL and Jalving M}, journal={Invest New Drugs}, volume={38}, number={5}, pages={1454-1462}}"}}, {"_id": "27756748", "pmid": 27756748, "title": "Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.", "journal": "Blood", "authors": ["Zhang QS", "Tang W", "Deater M", "Phan N", "Marcogliese AN", "Li H", "Al-Dhalimy M", "Major A", "Olson S", "Monnat RJ Jr", "Grompe M"], "date": "2016-12-15T00:00:00Z", "doi": "10.1182/blood-2015-11-683490", "meta_date_publication": "2016 Dec 15", "meta_volume": "128", "meta_issue": "24", "meta_pages": "2774-2784", "score": 50066.52, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves @<m>DISEASE_Cyclic_neutropenia</m> @DISEASE_MESH:C536227 @@@defective hematopoiesis@@@ and delays @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ formation in @DISEASE_Fanconi_Anemia @DISEASE_MESH:D005199 @@@Fanconi anemia@@@ @SPECIES_10090 @@@mice@@@.", "citations": {"NLM": "Zhang QS, Tang W, Deater M, Phan N, Marcogliese AN, Li H, Al-Dhalimy M, Major A, Olson S, Monnat RJ Jr, Grompe M. Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice. Blood. 2016 Dec 15;128(24):2774-2784. PMID: 27756748", "BibTeX": "@article{27756748, title={Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice.}, author={Zhang QS and Tang W and Deater M and Phan N and Marcogliese AN and Li H and Al-Dhalimy M and Major A and Olson S and Monnat RJ Jr and Grompe M}, journal={Blood}, volume={128}, number={24}, pages={2774-2784}}"}}]}